Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1024838.RAB4WBogCAPY4FLBHbnpKvsS1qxyGecIBEgRdsHcB-sJE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1024838.RAB4WBogCAPY4FLBHbnpKvsS1qxyGecIBEgRdsHcB-sJE130_assertion type Assertion NP1024838.RAB4WBogCAPY4FLBHbnpKvsS1qxyGecIBEgRdsHcB-sJE130_head.
- NP1024838.RAB4WBogCAPY4FLBHbnpKvsS1qxyGecIBEgRdsHcB-sJE130_assertion wasGeneratedBy ECO_0000203 NP1024838.RAB4WBogCAPY4FLBHbnpKvsS1qxyGecIBEgRdsHcB-sJE130_provenance.
- NP1024838.RAB4WBogCAPY4FLBHbnpKvsS1qxyGecIBEgRdsHcB-sJE130_assertion wasDerivedFrom befree-2016 NP1024838.RAB4WBogCAPY4FLBHbnpKvsS1qxyGecIBEgRdsHcB-sJE130_provenance.
- NP1024838.RAB4WBogCAPY4FLBHbnpKvsS1qxyGecIBEgRdsHcB-sJE130_assertion SIO_000772 23110092 NP1024838.RAB4WBogCAPY4FLBHbnpKvsS1qxyGecIBEgRdsHcB-sJE130_provenance.
- NP1024838.RAB4WBogCAPY4FLBHbnpKvsS1qxyGecIBEgRdsHcB-sJE130_assertion evidence source_evidence_literature NP1024838.RAB4WBogCAPY4FLBHbnpKvsS1qxyGecIBEgRdsHcB-sJE130_provenance.
- NP1024838.RAB4WBogCAPY4FLBHbnpKvsS1qxyGecIBEgRdsHcB-sJE130_assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1024838.RAB4WBogCAPY4FLBHbnpKvsS1qxyGecIBEgRdsHcB-sJE130_provenance.